Chao Wu
Chao Wu
Verified email at mskcc.org
Title
Cited by
Cited by
Year
Bioreducible hyperbranched poly (amido amine) s for gene delivery
J Chen, C Wu, D Oupicky
Biomacromolecules 10 (10), 2921-2927, 2009
1242009
Effect of innate glutathione levels on activity of redox-responsive gene delivery vectors
DS Manickam, J Li, DA Putt, QH Zhou, C Wu, LH Lash, D Oupický
Journal of controlled release 141 (1), 77-84, 2010
1032010
A rectal cancer organoid platform to study individual responses to chemoradiation
K Ganesh, C Wu, KP O’Rourke, BC Szeglin, Y Zheng, CEG Sauvé, ...
Nature medicine 25 (10), 1607-1614, 2019
932019
An important player in brine shrimp lethality bioassay: The solvent
C Wu
Journal of advanced pharmaceutical technology & research 5 (1), 57, 2014
572014
Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model
C Wu, XL Jiang, HW Shen, AM Yu
Biochemical pharmacology 78 (6), 617-624, 2009
432009
SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance
I Wasserman, LH Lee, S Ogino, MR Marco, C Wu, X Chen, J Datta, ...
Clinical Cancer Research 25 (6), 1948-1956, 2019
352019
Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N, N-dimethyltryptamine metabolism and pharmacokinetics
HW Shen, C Wu, XL Jiang, AM Yu
Biochemical pharmacology 80 (1), 122-128, 2010
332010
Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation
Z Zhang, C Zhou, X Li, SD Barnes, S Deng, E Hoover, CC Chen, YS Lee, ...
Cancer cell 37 (4), 584-598. e11, 2020
272020
Evaluation of pharmacokinetics of bioreducible gene delivery vectors by real-time PCR
QH Zhou, C Wu, DS Manickam, D Oupický
Pharmaceutical research 26 (7), 1581-1589, 2009
272009
Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro
QH Zhou, YZ You, C Wu, Y Huang, D Oupický
Journal of drug targeting 17 (5), 364-373, 2009
252009
Epithelial Smad4 deletion up-regulates inflammation and promotes inflammation-associated cancer
AL Means, TJ Freeman, J Zhu, LG Woodbury, P Marincola-Smith, C Wu, ...
Cellular and molecular gastroenterology and hepatology 6 (3), 257-276, 2018
242018
Opposing influence of intracellular and membrane thiols on the toxicity of reducible polycations
C Wu, J Li, Y Zhu, J Chen, D Oupický
Biomaterials 34 (34), 8843-8850, 2013
232013
对苯二甲酰氯合成
程永浩, 邹小毛, 任雪玲, 吴超, 杨华铮
化学试剂 25 (002), 118-118, 2003
212003
Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer
Z Zhang, WR Karthaus, YS Lee, VR Gao, C Wu, JW Russo, M Liu, ...
Cancer cell 38 (2), 279-296. e9, 2020
192020
Mismatch repair–deficient rectal cancer and resistance to neoadjuvant chemotherapy
A Cercek, GDS Fernandes, CS Roxburgh, K Ganesh, S Ng, ...
Clinical Cancer Research 26 (13), 3271-3279, 2020
192020
Synthesis of bisethylnorspermine lipid prodrug as gene delivery vector targeting polyamine metabolism in breast cancer
Y Dong, Y Zhu, J Li, QH Zhou, C Wu, D Oupický
Molecular pharmaceutics 9 (6), 1654-1664, 2012
152012
Bisethylnorspermine lipopolyamine as potential delivery vector for combination drug/gene anticancer therapies
Y Dong, J Li, C Wu, D Oupický
Pharmaceutical research 27 (9), 1927-1938, 2010
92010
Design and synthesis of novel fluorine-containing acrylates
YC Wu, C Wu, XM Zou, FZ Hu, HZ Yang
Chinese Chemical Letters 16 (10), 1293-1296, 2005
62005
新型含嘧啶氨基吡唑类化合物的合成及生物活性
邹小毛, 吴超, 周传政, 任雪玲, 杨华铮
高等学校化学学报 26 (003), 456-460, 2005
62005
氨基酸生物合成中除草剂靶酶研究进展
任雪玲, 吴超, 杨华铮
农药 44 (9), 395-398, 2005
52005
The system can't perform the operation now. Try again later.
Articles 1–20